The Laboratory Service Department of the Food and Drugs Authority (FDA) of Ghana, has attained the internationally recognized ISO/IEC 17025:2005 accreditation for several quality control tests.
This accreditation, demonstrates the technical competence of the laboratory and its quality management system.
This is seen as a big boost for the FDA, as it contributes to the Laboratory Service Department’s mandate to provide trustworthy data to the Ghana’s Ministry of Health (MoH) and ensure the availability of quality-assured foods and medicines in Ghana.
ACLASS, an internationally recognized accrediting body based in Alexandria, Virginia, awarded the ISO/IEC accreditation after eight key analytical tests.
Technical and financial assistance from the Promoting the Quality of Medicines (PQM) program, funded by the United States Agency for International Development (USAID) with support from the US Pharmacopeial Convention (USP), was instrumental in helping the Laboratory Service Department achieve this important accreditation.
PQM works with regulatory authorities in developing countries around the world to safeguard the quality of medicines, with a particular focus on priority medicines for treating malaria, HIV/AIDS and tuberculosis.
“The ISO/IEC 17025:2005 accreditation positions FDA Ghana among Africa’s elite laboratories in the area of pharmaceutical quality control,” said Mr. Hudu Mogtari, Chief Executive Officer of FDA Ghana.
“With this achievement, we have demonstrated our ability to produce reliable results that will give authorities—within Ghana and internationally—confidence in decisions impacting the health of patients,” he added.
“Much of the laboratory work essential to medicines quality testing entails complex methods and procedures that must be followed meticulously to ensure accurate results. The importance of this accuracy cannot be understated,” said Director of the PQM Program, Dr. Patrick Lukulay.
“With this accreditation, FDA demonstrates that its technical operations and administrative systems are functioning at the highest quality levels by international standards, producing accurate, valid results that can be trusted by the international community.”
“Obtaining this world-class accreditation is a laborious process that demonstrates a strong commitment to excellence at every level of the laboratory,” said Dr. Sureyya Hornston, U.S. President’s Malaria Initiative (PMI) Technical Advisor of USAID/Ghana.
“Thanks to FDA’s dedication to continuous improvement, the laboratory will be in a position to help improve access to good quality medicines in Ghana, especially anti-malarials in the entire region. The USAID mission in Ghana is proud to have supported this achievement.”
The U.S. Pharmacopeia Convention (USP) is a global health organization that improves lives through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP’s standards are used worldwide. For more information about USP visit